Orthopedic Implant Contracting, Round II
For suppliers, the first generation of orthopedic implant contracts was disappointing, to say the least. Hospital purchasing groups disagree--but their second generation contracts subtly address supplier dissatisfactions. Still, in an era of shifting market leaders and a consolidating industry, will contracting ever really catch on?
You may also be interested in...
After double-digit growth in formulation sales across geographies in the fourth quarter, Aurobindo expects to continue the momentum this fiscal year. Meanwhile, it might look for partners for its biologics business, which is now transferred to its fully owned subsidiary for $48m.
The European Commission has updated its rolling plan. It now looks as if current member state rules for non-medical products could persist beyond the 26 May 2021 deadline.
GSK launches a 100% natural saline spray in the UK to compliment its Piri hayfever brand portfolio.